COVID‐19 severity from Omicron and Delta SARS‐CoV‐2 variants
The Omicron variant of SARS‐CoV‐2 achieved worldwide dominance in late 2021. Early work suggests that infections caused by the Omicron variant may be less severe than those caused by the Delta variant. We sought to compare clinical outcomes of infections caused by these two strains, confirmed by who...
Saved in:
Published in | Influenza and other respiratory viruses Vol. 16; no. 5; pp. 832 - 836 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
John Wiley & Sons, Inc
01.09.2022
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The Omicron variant of SARS‐CoV‐2 achieved worldwide dominance in late 2021. Early work suggests that infections caused by the Omicron variant may be less severe than those caused by the Delta variant. We sought to compare clinical outcomes of infections caused by these two strains, confirmed by whole genome sequencing, over a short period of time, from respiratory samples collected from SARS‐CoV‐2 positive patients at a large medical center. We found that infections caused by the Omicron variant caused significantly less morbidity, including admission to the hospital and requirement for oxygen supplementation, and significantly less mortality than those caused by the Delta variant. |
---|---|
Bibliography: | Funding information National Institute of Allergy and Infectious Diseases, Grant/Award Numbers: R21AI142321‐02S1, R21AI149262, R21AI154016, R21AI142321; National Institutes of Health, Grant/Award Numbers: G20RR030956, P30EY08126, P30CA68485, UL1RR024975; National Heart, Lung, and Blood Institute, Grant/Award Numbers: R01HL146401, K23HL148638; Centers for Disease Control and Prevention, Grant/Award Number: 75D3012110094 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Funding information National Institute of Allergy and Infectious Diseases, Grant/Award Numbers: R21AI142321‐02S1, R21AI149262, R21AI154016, R21AI142321; National Institutes of Health, Grant/Award Numbers: G20RR030956, P30EY08126, P30CA68485, UL1RR024975; National Heart, Lung, and Blood Institute, Grant/Award Numbers: R01HL146401, K23HL148638; Centers for Disease Control and Prevention, Grant/Award Number: 75D3012110094 |
ISSN: | 1750-2640 1750-2659 |
DOI: | 10.1111/irv.12982 |